Calyxt to Present at the H.C Wainwright BioConnect Virtual Conference

Roseville, MN – Tuesday, January 4, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that a presentation given by management at the H.C Wainwright BioConnect Conference will be available for viewing online on Monday, January 10, 2022 at 7:00 a.m. ET. The conference will be held in a virtual meeting format.

H.C. Wainwright BioConnect Conference

Date: Monday, January 10, 2022

Time: 7:00 a.m. ET (4:00 a.m. PT)


To schedule a meeting with management, please reach out to

The presentation will be available for viewing and replay from the Investors section of Calyxt’s website at

About Calyxt:

Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit

PlantSpring, BioFactory, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.


Calyxt Media Contact:Calyxt Investor Relations Contact:
David Rosen/John Garabo/Michael Barron Argot Partners (212) 600-1902 media@calyxt.comSherri Spear/Cameron Willis Argot Partners (212) 600-1902  
Calyxt Business Development Contact: 
Sarah Reiter Calyxt, Inc. (612) 427-7881